Biopharma AI
By
How Xsolis’ AI-Driven Dragonfly Clinched the 2025 MedTech’s ‘Clinical Efficiency Innovation Award’? Targets the $1 Trillion U.S. Healthcare Waste Crisis Clinical Efficiency Innovation Award
Key Highlights Xsolis Sets New Standard in AI-Powered Clinical EfficiencyTennessee-based AI tech firm Xsolis has won top honors…
Can MIT and Recursion’s New AI Model Boltz-2 Slash Drug Discovery Time by 1000x and Outperform AlphaFold3?
Key Takeaways• Boltz-2 delivers AI-driven binding affinity predictions 1000x faster than traditional free energy methods—dramatically accelerating virtual screening…
Is Optic and Mechanica’s AI Venture Model the Future of Biotech Creation? Strategic Expansion Unifies Drug Discovery and Business Insight at Scale
Key Highlights Strategic Collaboration to Power AI-Led Biotech GrowthOptic, Inc., a pioneer in AI platforms for biopharma, has…
Is the OBI Pharma–TegMine Therapeutics ADC Deal the Next Leap in Precision Oncology Using Glycan-Based Technologies?
Key Highlights 1. Powering the Next-Gen ADC Revolution: OBI’s GlycOBI® Meets TegMine’s TegMiner™The collaboration between Taiwan-based OBI Pharma…
How Is XtalPi’s Expanded Collaboration With Pfizer Set to Transform AI-Driven Small Molecule Drug Discovery?
Key Takeaways Empowering Next-Gen AI Platforms for Predictive Drug DiscoveryXtalPi and Pfizer have extended their strategic partnership to…
Is AI-Engineered HMBD-002 the Next Big Immunotherapy? Hummingbird Bioscience Signs $290M Global Licensing Deal with Percheron Therapeutics
Key Highlights Strategic Global Licensing Deal Hummingbird Bioscience has signed a worldwide licensing agreement with Percheron Therapeutics for…
